Role of Prophylactic Transamine in Reducing Blood Loss during Elective Cesarean Delivery

Authors

  • Saima Irfan Department of Obstetrics and Gynecology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Tehreem Yazdani Department of Obstetrics and Gynecology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Salma Nisar Department of Obstetrics and Gynecology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Maliha Khawar Department of Obstetrics and Gynecology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Hira Shafqat Department of Obstetrics and Gynecology, Pak Emirates Military Hospital/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74iSUPPL-2.7845

Keywords:

Blood Loss, Hemoglobin, Transamine

Abstract

Objective: The purpose of the current research was to see how effective Tranexamic Acid is for minimizing loss of blood after 
elective cesarean section.
Study Design: Interventional, randomized, parallel-group study.
Place and Duration of Study: Department of Obstetrics and Gynecology, Pak Emirates Military Hospital, Rawalpindi Pakistan, 
from August 2020 to August 2021.
Methodology: Computer-generated random number tables were used to assign 130 females wo were scheduled for cesarean
surgery to the Study or Control groups. The research group received TXA and regular treatment, while control group received 
just routine care. The gravimetric technique was used to determine blood loss in both groups. The percentage difference 
between hemoglobin levels before and after the operation was determined, the blood loss and percentage drop in hemoglobin 
were the primary outcome variables. The secondary outcomes of the study include the duration of operation, adverse effects, 
percentage of patients who lost more than 500ml blood and require for additional uterotonics. The outcome variables were 
compared using the unpaired t-test and the Chi-square test.
Results: Blood loss was significantly lower in the study group from placental delivery until the end of the operation. In the 
study group, 5(9.3%) of patients had a drop in hemoglobin of more than 10%, whereas 25(39%) of subjects had a drop of more 
than 10% loss of blood in the process of Lower Segment Caesarean Section.
Conclusion: TXA may be administered safely and successfully in Lower Segment Caesarean Section as its use was not linked to 
any adverse effects.

Downloads

Download data is not yet available.

References

Kamilya G, Seal SL, Mukherji J, Bhattacharyya SK, Hazra A.

Maternal mortality and cesarean delivery: an analytical

observational study. Journal of Obstetrics and Gynaecology

Research. 2018; 36(2): 248–253.

Ronsmans C, Graham WJ, group LMSS steering. Maternal

mortality: who, when, where, and why. The lancet 2016; 368(9542):

–1200.

Mohamed El-Seadawy Ghanem A, Fawzy Mohamed M, Khamis

Galal S. ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN

REDUCING BLOOD LOSS DURING ELECTIVE CESAREAN

SECTION. Al-Azhar Medical Journal 2021; 50(3): 1871–1880.

Geller SE, Goudar SS, Adams MG, Naik VA, Patel A, Bellad MB, et

al. Factors associated with acute postpartum hemorrhage in lowrisk women delivering in rural India. International Journal of

Gynecology & Obstetrics 2018; 101(1): 94–99.

Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labor and

caesarean delivery: implications for the anaesthesiologist. Current

Opinion in Anesthesiology 2017; 24(3): 255–261.

Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Antifibrinolytic agents in post partum haemorrhage: a systematic

review. BMC pregnancy and childbirth 2019; 9(1): 1–6.

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ,

Fergusson DA, et al. Antifibrinolytic use for minimizing

perioperative allogeneic blood transfusion. Cochrane database of

systematic reviews 2018; (1).

Matteson KA, Rahn DD, Wheeler TL. Non-surgical management

of heavy menstrual bleeding: A systematic review and practice

guidelines. Obstetrics and gynecology 2019; 121(3): 632.

Sentilhes L, Winer N, Azria E, Sénat M-V, Le Ray C, Vardon D, et

al. Tranexamic acid for the prevention of blood loss after vaginal

delivery. New England Journal of Medicine 2018; 379(8): 731–742.

Ducloy-Bouthors A-S, Jude B, Duhamel A, Broisin F, Huissoud C,

Keita-Meyer H, et al. High-dose tranexamic acid reduces blood

loss in postpartum haemorrhage. Critical care 2017; 15(2): 1–10.

Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous

tranexamic acid administration on blood loss during and after

cesarean delivery. Int J Gynecol Obstet 2018; 115(3): 224–226.

Geller SE, Goudar SS, Adams MG, Naik VA, Patel A, Bellad MB, et

al. Factors associated with acute postpartum hemorrhage in lowrisk women delivering in rural India. Int J Gynaecol Obstet 2008;

(1): 94-99.

https://doi.org/10.1016/j.ijgo.2007.08.025

Shahid A, Khan A. Tranexamic acid in decreasing blood loss

during and after caesrean section. J Coll Physcian Surg Pak 2013;

(7): 459-462.

Dunn CJ, Goa KL. Tranexamic acid. Drugs 2018; 57(6): 1005–1032.

Walzman M, Bonnar J. Effects of tranexamic acid on the

coagulation and fibrinolytic systems in pregnancy complicated by

placental bleeding. In: New Toxicology for Old Springer; 2017:

–220.

Picetti R, Shakur-Still H, Medcalf RL, Standing JF, Roberts I. What

concentration of tranexamic acid is needed to inhibit fibrinolysis?

A systematic review of pharmacodynamics studies. Blood

Coagulation & Fibrinolysis 2019; 30(1): 1.

Pabinger I, Fries D, Schöchl H, Streif W, Toller W. Tranexamic acid

for treatment and prophylaxis of bleeding and hyperfibrinolysis.

Wiener klinische Wochenschrift. 2017; 129(9): 303–316.

Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood

loss reduced by tranexamic acid during and after caesarian

section: a multi-center, randomized trial. European Journal of

Obstetrics & Gynecology and Reproductive Biology 2019; 112(2):

–157.

Falana O, Patel G. Efficacy and safety of tranexamic acid versus ϵaminocaproic acid in cardiovascular surgery. Annals of

Pharmacotherapy 2017; 48(12): 1563–1569.

Takagi H, Ando T, Umemoto T. Seizures associated with

tranexamic acid for cardiac surgery: A meta-analysis of

randomized and non-randomized studies. The Journal of

cardiovascular surgery 2017; 58(4): 633–641.

Yehia AH, Koleib MH, Abdelazim IA, Atik A. Tranexamic acid

reduces blood loss during and after cesarean section: a double

blinded, randomized, controlled trial. Asian Pacific Journal of

Reproduction 2019; 3(1): 53–56.

Downloads

Published

30-09-2024

Issue

Section

Original Articles

How to Cite

1.
Irfan S, Yazdani T, Nisar S, Khawar M, Shafqat H. Role of Prophylactic Transamine in Reducing Blood Loss during Elective Cesarean Delivery. Pak Armed Forces Med J [Internet]. 2024 Sep. 30 [cited 2025 Jan. 19];74(SUPPL-2):S339-S342. Available from: https://pafmj.org/PAFMJ/article/view/7845